Inside Innovation

Seattle-based biotech Phase Genomics founder Ivan Liachko didn’t plan on founding a company. After discovering techniques revealing how DNA is organized inside a cell and

Bristol Myers Squibb Senior Scientist Kayla Garrett is a Puget Sound Business Journal 40 under 40 honoree. She has worked towards a new approach to

An international research team led by the University of Washington scientists has successfully applied reinforcement learning, a type of machine learning where a computer program

According to CBRE’s new life sciences outlook report, Seattle life sciences employment and National Institutes of Health (NIH) funding have experienced rapid growth since 2019.

Seattle-based biotech Omeros received a $6.7 million grant from the National Institute on Drug Abuse to test the company’s cocaine treatment drug candidate OMS527 in

A new report from CBRE revealed that, despite the current economic state, the life science industry’s demand for lab space is still above pre-pandemic levels

Artificial intelligence has advanced many operations and is even finding ways to revolutionize biology innovations that will accelerate drug discovery and other advances in life

The inspiration behind the Invent at Seattle Children’s Postdoctoral Scholars Program began at a workshop. Eric Nealy, who saw what the life sciences field could

David Younger, co-founder and CEO of Seattle-based biotech A-Alpha Bio is a Puget Sound Business Journal 40 under 40 honoree. Younger co-founded the company in

The inspiration behind the Invent at Seattle Children’s Postdoctoral Scholars Program began at a workshop. Eric Nealy, who saw what the life sciences field could

The Seattle-area company, Sonoma Biotherapeutics has partnered with Regeneron in a $75 million upfront deal with plans to co-develop therapies to treat Crohn’s disease and

Biotech giant Moderna is making its way to Seattle with a new office opening in South Lake Union on April 4. The company plans to